Author:
McCallum Matthew,Bassi Jessica,Marco Anna De,Chen Alex,Walls Alexandra C.,Iulio Julia Di,Tortorici M. Alejandra,Navarro Mary-Jane,Silacci-Fregni Chiara,Saliba Christian,Agostini Maria,Pinto Dora,Culap Katja,Bianchi Siro,Jaconi Stefano,Cameroni Elisabetta,Bowen John E.,Tilles Sasha W,Pizzuto Matteo Samuele,Guastalla Sonja Bernasconi,Bona Giovanni,Pellanda Alessandra Franzetti,Garzoni Christian,Van Voorhis Wesley C.,Rosen Laura E.,Snell Gyorgy,Telenti Amalio,Virgin Herbert W.,Piccoli Luca,Corti Davide,Veesler David
Abstract
AbstractSARS-CoV-2 entry is mediated by the spike (S) glycoprotein which contains the receptor-binding domain (RBD) and the N-terminal domain (NTD) as the two main targets of neutralizing antibodies (Abs). A novel variant of concern (VOC) named CAL.20C (B.1.427/B.1.429) was originally detected in California and is currently spreading throughout the US and 29 additional countries. It is unclear whether antibody responses to SARS-CoV-2 infection or to the prototypic Wuhan-1 isolate-based vaccines will be impacted by the three B.1.427/B.1.429 S mutations: S13I, W152C and L452R. Here, we assessed neutralizing Ab responses following natural infection or mRNA vaccination using pseudoviruses expressing the wildtype or the B.1.427/B.1.429 S protein. Plasma from vaccinated or convalescent individuals exhibited neutralizing titers, which were reduced 3-6 fold against the B.1.427/B.1.429 variant relative to wildtype pseudoviruses. The RBD L452R mutation reduced or abolished neutralizing activity of 14 out of 35 RBD-specific monoclonal antibodies (mAbs), including three clinical-stage mAbs. Furthermore, we observed a complete loss of B.1.427/B.1.429 neutralization for a panel of mAbs targeting the N-terminal domain due to a large structural rearrangement of the NTD antigenic supersite involving an S13I-mediated shift of the signal peptide cleavage site. These data warrant closer monitoring of signal peptide variants and their involvement in immune evasion and show that Abs directed to the NTD impose a selection pressure driving SARS-CoV-2 viral evolution through conventional and unconventional escape mechanisms.
Publisher
Cold Spring Harbor Laboratory
Cited by
101 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献